Logo by S. Popis

“Optimal Nutrition” and “Selective Currents” as a treatment of
atherosclerosis and Buerger’s disease of the lower limbs.

MD Jan Kwasniewski

This paper compares effects of the “selective current” treatment received by
patients of Military Sanatorium in Ciechocinek during the years 1969 – 1974,
who were on a typical diet (Group A), with effects of a similar “selective current”
treatment received by patients of Health Academy “Arkadia” in Ciechocinek and
Cedzyna during the years 1987 – 1989, who were on the “optimal diet”
(Group B).

Both groups consisted of patients suffering from atherosclerosis (AS) or
Buerger’s disease also known as thromboagiitis obliterans (TAO), of the lower

Group A consisted of 100 patients with AS and 60 patients with TAO, all of whom
spent a standard period of 24 days in the sanatorium, and who were fed
a standard 5 meal/day sanatorium diet. Group B consisted of 190 patients
with AS and 53 with TAO all of whom spent a period of 14 days in one of the
Arkadias, and who were fed the “optimal diet”, structured in such a way as
to deliver about 65% of caloric intake as fat (mainly animal), about 20% as
proteins (exclusively animal) and 15% as carbohydrate (mainly starch). On
average, the patients in the Group B, particularly those suffering from TAO,
presented with markedly more advanced disease stage than patients in the
Group A. Thus, out of 53 of those with TAO in Group B, as many as 41 had later
stages of the disease, characterised by extensive ulceration of lower limbs.
Of those, 36 also had severe neuralgic pain at rest (stage IV). In contrast, the
majority of patients in Group A presented with mild (stage I) TAO, with only
a few showing minor ulcerations, but no resting pain (stage II). In Group B TAO
patients, only 29 of all lower limbs were suitable for testing using the exertion
test. The remaining 77 limbs were either missing (amputation) or could not be
tested by either of these methods due to severe resting pains.

In all patients, severity of disease assessment was performed by testing before
the start of the “selective current” treatment and again at the end of a 24-day
or 14-day stay. In all patients, the testing procedure included the so-called
distance of lameness (walking distance until the pain threshold is reached) and
the so-called Kwasniewski’s test (calf muscle strength test performed by
raising the whole body weight on the toes of one foot while standing with an
extended arm against the wall). The effects of treatment were assessed using
four disease parameters as described below in the legend of Table 1.
In addition, only patients from Group A were assessed in terms of shortening of
the time of motor chronaxy of calf muscle, improvement of oscillometric
indicator measured on the calf, and an increase in the skin surface temperature,
measured in °C at eight predetermined points on the feet.

All patients were treated with the “selective current” generated by the
“Pentapuls” current generator (made to order for the author). All patients
received treatment in the supine position. One stimulating electrode was
positioned under the feet and the other under the lower lumbar region.
The polarity of electrodes (direction of current) was not maintained
constant between each session or for each patient.
The same type of electrical current – the so-called PS current (parasympathetic;
12 Hz, 110V) was used for each patient. The amperage of current (in the range
of 1 - 62 mA) was set individually so each patient could feel a strong current
sensation, without undue discomfort. That type of electrical current selectively
stimulates peripheral neurones of the parasympathetic system, causing dilation
of arteries and lymphatics, and improvement in venous circulation. The
“selective current” sessions in Group A were of 15-min duration and were
applied over 16 consecutive days (total duration of 240 min), whereas for
those in the Group B, sessions lasted 20 min and were performed over 10 days
in succession (total duration of 200 min).

The objective comparison between the improvements achieved by the two
groups of patients is difficult, because the severity of the disease, particularly
TAO, was markedly greater in Group B. However, as can be seen in Table 1,
greater improvement in most of the assessed disease parameters was
obtained by Group B patients, even though the overall length of treatment
period with the “selective currents” and the stay in the Arkadia were shorter.
The most striking
improvements were obtained in terms of the distance of lameness and the calf
muscle strength in the patients who, apart from benefiting from the “selective
current” treatment, also clearly benefited from dietary change to the optimal
model of human nutrition as devised by the author. It has to be stressed that
none of the sanatorium patients, suffering from either AS or TAO, who did not
receive the “selective current” treatment showed any improvement in their
disease symptoms during their stay. However, there are no records on how
many of such "control" patients visited the sanatorium during the study period.

A similar improvement in muscle strength (+68%) was also shown by 212
patients with Multiple Sclerosis who underwent the same treatment in Arkadias
during the same period (results not shown).

Table 1. Changes in the objective disease parameters (see description below)
after treatment with the “selective current” in patients with atherosclerosis
and Buerger’s
disease of lower limbs.


Number of patients
Parameter I
Parameter II
Parameter III
Parameter IV

Patients with AS

20 (20%)
52 (27%)
Patients with TAO
14 (23%)


8 (15%)






* - group received the selective current treatment without optimal nutrition

** - group received the selective current treatment with the optimal nutrition

Parameter I – number of patients who showed no lameness (up to 5000 m) as
a result of treatment

Parameter II – increase in the distance of lameness.

Parameter III – increase in the muscle strength measured by Kwasniewski’s

Parameter IV – reduction in the duration of pain period after exertion.

In Group A patients with AS, the “selective current” treatment also resulted in
a mean 38% reduction in the time of motor chronaxy of calf muscle, a 42%
improvement of the oscillometric indicator measured on the calf, and a mean
2.4°C increase in the skin temperature. In the patients with TAO, the same
changes were 36%, 41% and 1.9°C, respectively.

Discussion and conclusions

These results clearly indicate that the “selective current” treatment can produce
marked improvements in the objective disease parameters of AS and TAO of
lower limbs.
These improvements are greater and longer lasting than those offered by any
method of treatment presently known, pharmacological or surgical.
Such improvements have been achieved to a similar degree in each and every
treated patient, and from my experience persist for months or even years in
those who have not adopted the “optimal nutrition”. Most importantly,
concomitant implementation of the “optimal diet” delivers even greater
improvement in every one of these parameters in a very short period of time.
In these patients, a complete abatement
of disease symptoms occurs normally within a few months, and eventually a full
recovery (cure) is obtained, provided the patient continues the “optimal diet”.

In summary, the combined treatment consisting of the “selective current”
stimulation and the implementation of the “optimal nutrition” is the only form
of treatment known currently to man which produces marked and prolonged
improvements in the objective parameters, and an eventual cure, of clinically
incurable vascular diseases, AS and TAO.
Therefore, the "optimal nutrition" is the causal treatment of those diseases.
This form of treatment is cheap, easy to implement and does not involve any
mechanical or
chemical intervention. Finally, neither the “selective currents” nor the “optimal
nutrition” are detrimental to human health. In fact, in my clinical practice,
involving thousands of patients, the “optimal nutrition” with or without
treatment with the “selective currents” has been shown to markedly and
permanently improve symptoms, or to cure, many other diseases including
diabetes (type I & II), Alzheimer’s and Parkinson’s disease, asthma, migraine,
neurosis, digestive tract diseases and others.

| Up | Home | Feedback |
Designs and implementation by S. Popis. All Rights Reserved